Literature DB >> 12413593

Effects of homocysteine thiol group on fibrin networks: another possible mechanism of harm.

Ana M Lauricella1, Irene L Quintana, Lucía C Kordich.   

Abstract

On the basis of growing clinical evidence, it is well known that elevated plasma homocysteine (Hcy) levels are associated with higher risk of venous and arterial thrombosis. Several experimental studies have been carried out in order to elucidate the mechanisms involved that still remain unclear. The aim of our study was to evaluate the homocysteine effects on formation and structure of plasmatic fibrin network. We also assayed homocystine and cysteine to determinate possible participation of thiol group in the tested activity. Aliquots of a pool of plasma incubated separately with sulfur compounds were clotting with thrombin. Fibringeneration and fibrin networks were evaluated by kinetic studies and scanning electronic microscopy, respectively. No significant differences were observed on fibrin generation of the substances assayed in comparison to control. The scanning electronic microscopy showed that Hcy-associated networks were different from control, with shorter, thicker and more branched fibers, resulting in a more compact structure and probably more resistant to fibrinolysis. The thiol group would be involved in this effect. Our findings would be a new contribution to elucidate the mechanisms involved in harmful effects associated to hyperhomocysteinemia.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12413593     DOI: 10.1016/s0049-3848(02)00191-3

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  5 in total

1.  Comparison of the effect of different homocysteine concentrations on clot formation using human plasma and purified fibrinogen.

Authors:  Rita Marchi; Zoila Carvajal; John W Weisel
Journal:  Thromb Haemost       Date:  2008-02       Impact factor: 5.249

2.  Impact of homocysteine-thiolactone on plasma fibrin networks.

Authors:  Valeria Genoud; Ana María Lauricella; Lucía C Kordich; Irene Quintana
Journal:  J Thromb Thrombolysis       Date:  2014-11       Impact factor: 2.300

3.  Allicin improves carotid artery intima-media thickness in coronary artery disease patients with hyperhomocysteinemia.

Authors:  De-Shan Liu; Shu-Li Wang; Jun-Mei Li; Er-Shun Liang; Ming-Zhong Yan; Wei Gao
Journal:  Exp Ther Med       Date:  2017-06-28       Impact factor: 2.447

4.  Admission homocysteine is an independent predictor of spontaneous reperfusion and early infarct-related artery patency before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction.

Authors:  Jing Li; Ying Zhou; Yaowen Zhang; Jingang Zheng
Journal:  BMC Cardiovasc Disord       Date:  2018-06-25       Impact factor: 2.298

5.  Effects of Hyperhomocysteinemia on the Platelet-Driven Contraction of Blood Clots.

Authors:  Rustem I Litvinov; Alina D Peshkova; Giang Le Minh; Nail N Khaertdinov; Natalia G Evtugina; Guzel F Sitdikova; John W Weisel
Journal:  Metabolites       Date:  2021-06-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.